Coburn Hobar

Deucravacitinib, a Tyrosine Kinase 2 Inhibitor, in Systemic Lupus Erythematosus: A Phase II, Randomized, Double-Blind, Placebo-Controlled Trial

Arthritis & Rheumatology · 2023 · 209 citations

Injection-site burning and stinging in patients with rheumatoid arthritis using injectable biologics

Current Medical Research and Opinion · 2011 · 22 citations